Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral - PhysicianPharm

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

Mohammad Naghavi-Behzad, Marianne Vogsen, Rasmus Molgard Vester, Maiken Olsen, Hjalte Oltmann, Poul-Erik Braad, Jon Thor Asmussen, Oke Gerke, Werner Vach, Kristian Kidholm, Annette Raskov Kodahl, Wolfgang Weber and Malene Hildebrandt
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 129;
Mohammad Naghavi-Behzad
1Department of Clinical Research University of Southern Denmark Odense Denmark
2Department of Nuclear Medicine Odense University Hospital Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marianne Vogsen
2Department of Nuclear Medicine Odense University Hospital Odense Denmark
3Department of Oncology Odense University Hospital Odense Denmark
1Department of Clinical Research University of Southern Denmark Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rasmus Molgard Vester
2Department of Nuclear Medicine Odense University Hospital Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maiken Olsen
2Department of Nuclear Medicine Odense University Hospital Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hjalte Oltmann
2Department of Nuclear Medicine Odense University Hospital Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Poul-Erik Braad
2Department of Nuclear Medicine Odense University Hospital Odense Denmark
1Department of Clinical Research University of Southern Denmark Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Thor Asmussen
1Department of Clinical Research University of Southern Denmark Odense Denmark
4Department of Radiology Odense University Hospital Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oke Gerke
1Department of Clinical Research University of Southern Denmark Odense Denmark
2Department of Nuclear Medicine Odense University Hospital Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Vach
5Basel Academy for Quality and Research in Medicine Basel Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristian Kidholm
6Centre for Innovative Medical Technology Odense University Hospital Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette Raskov Kodahl
1Department of Clinical Research University of Southern Denmark Odense Denmark
3Department of Oncology Odense University Hospital Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Weber
7Department of Nuclear Medicine Technical University of Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malene Hildebrandt
6Centre for Innovative Medical Technology Odense University Hospital Odense Denmark
2Department of Nuclear Medicine Odense University Hospital Odense Denmark
1Department of Clinical Research University of Southern Denmark Odense Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 62 no. supplement 1 129

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 18, 2021.

Copyright & Usage 
© 2021

Author Information

  1. Mohammad Naghavi-Behzad1,2,
  2. Marianne Vogsen2,3,1,
  3. Rasmus Molgard Vester2,
  4. Maiken Olsen2,
  5. Hjalte Oltmann2,
  6. Poul-Erik Braad2,1,
  7. Jon Thor Asmussen1,4,
  8. Oke Gerke1,2,
  9. Werner Vach5,
  10. Kristian Kidholm6,
  11. Annette Raskov Kodahl1,3,
  12. Wolfgang Weber7 and
  13. Malene Hildebrandt6,2,1
  1. 1Department of Clinical Research University of Southern Denmark Odense Denmark
  2. 2Department of Nuclear Medicine Odense University Hospital Odense Denmark
  3. 3Department of Oncology Odense University Hospital Odense Denmark
  4. 4Department of Radiology Odense University Hospital Odense Denmark
  5. 5Basel Academy for Quality and Research in Medicine Basel Switzerland
  6. 6Centre for Innovative Medical Technology Odense University Hospital Odense Denmark
  7. 7Department of Nuclear Medicine Technical University of Munich Munich Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2021 to April 2025

AbstractFullPdf
May 20214300
Jun 20218300
Jul 20217700
Aug 20216300
Sep 20212200
Oct 20211300
Nov 20211800
Dec 20211600
Jan 20224200
Feb 20221200
Mar 20223000
Apr 20225500
May 20222600
Jun 20222600
Jul 20221500
Aug 2022900
Sep 2022800
Oct 2022600
Nov 20221000
Dec 2022400
Jan 2023500
Feb 2023100
Mar 20231600
Apr 2023400
May 2023400
Jun 20231100
Jul 2023200
Aug 2023300
Sep 2023500
Oct 2023400
Nov 2023800
Dec 2023800
Jan 2024800
Feb 2024300
Mar 2024400
Apr 20242100
May 2024700
Jun 20242700
Jul 20246900
Aug 20247100
Sep 2024600
Oct 2024800
Nov 2024900
Dec 2024700
Jan 2025600
Feb 2025600
Mar 2025400
Apr 20251300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT
Mohammad Naghavi-Behzad, Marianne Vogsen, Rasmus Molgard Vester, Maiken Olsen, Hjalte Oltmann, Poul-Erik Braad, Jon Thor Asmussen, Oke Gerke, Werner Vach, Kristian Kidholm, Annette Raskov Kodahl, Wolfgang Weber, Malene Hildebrandt
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 129;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT
Mohammad Naghavi-Behzad, Marianne Vogsen, Rasmus Molgard Vester, Maiken Olsen, Hjalte Oltmann, Poul-Erik Braad, Jon Thor Asmussen, Oke Gerke, Werner Vach, Kristian Kidholm, Annette Raskov Kodahl, Wolfgang Weber, Malene Hildebrandt
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 129;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral - PhysicianPharm

  • Evaluation of myocardial perfusion scintigraphy SPECT and CT images in patients with a history of COVID-19
  • Can absorbed radiation doses by organs and tumors after PRRT be estimated from a single SPECT/CT study?
  • Semiconducting polymers enhance Cerenkov radiation energy transfer for multimodal cancer theranostics
Show more Oral - PhysicianPharm

Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

  • Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers
  • A Phase 3 study of 18F-DCFPyL-PET/CT in Patients with Biochemically Recurrent Prostate Cancer (CONDOR): An Analysis of Disease Detection Rate and Positive Predictive Value (PPV) by Anatomic Region
  • Ga-68-FAPI for sarcoma imaging: Data from the FAPI-PET prospective observational trial
Show more Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire